
Keywords: ضد اسهال; Berberine; Inflammatory bowel disease; Anti-inflammatory mechanisms; Antinociceptive; Epithelial barrier protection; Anti-diarrhoeal; AP1; activator protein 1; ATF; activating transcription factor; COX-2; cyclooxygenase-2; ERK1/2; extracellular signal-reg